about
Store-independent activation of Orai1 by SPCA2 in mammary tumorsDengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible lightPublic Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case StudiesHepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history?Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.Antibodies to Leptospira among blood donors in higher-risk areas of Australia: possible implications for transfusion safetyEpidemiology of dengue in a high-income country: a case study in Queensland, AustraliaSeroprevalence of Antibodies to Ross River and Barmah Forest Viruses: Possible Implications for Blood Transfusion Safety After Extreme Weather Events.Projections of increased and decreased dengue incidence under climate change.Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply.The Australian Public is Still Vulnerable to Emerging Virulent Strains of West Nile Virus.Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231Assessing the threat of chikungunya virus emergence in Australia.The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.Cytomegalovirus disease in immunocompetent adults.Localization of plasma membrane and secretory calcium pumps in the mammary gland.The impact on blood donor screening for human immunodeficiency virus, hepatitis C virus, and hepatitis B virus using plasma from frozen-thawed plasma preparation tubes.Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal.Epidemic Potential for Local Transmission of Zika Virus in 2015 and 2016 in Queensland, Australia.Implications of dengue outbreaks for blood supply, Australia.Calcium and cancer: targeting Ca2+ transport.A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples.Mitigating the Risk of Transfusion-Transmitted Dengue in Australia.Is Zika virus a potential threat to the Australian Blood Supply?Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.Riboflavin and ultraviolet light: impact on dengue virus infectivity.Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventories.Genetic factors associated with iron storage in Australian blood donors.Low seroprevalence of Murray Valley encephalitis and Kunjin viruses in an opportunistic serosurvey, Victoria 2011.Incorporation of fluorescein conjugated function-spacer-lipid constructs into the red blood cell membrane facilitates detection of labeled cells for the duration of ex-vivo storage.Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light.Detection of emergent strains of West Nile virus with a blood screening assay.Platelet concentrates modulate myeloid dendritic cell immune responses.First confirmed case of transfusion-transmitted hepatitis E in Australia.Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation.Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate.Hepatitis E virus RNA in Australian blood donations.Re-evaluating the residual risk of transfusion-transmitted Ross River virus infection.The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components.
P50
Q24301440-848BD02C-1CCD-4F66-A0AD-C89179F53BA7Q26252208-C4AEF12F-91B0-4CAE-AB57-C1A43E5E4D3CQ27010597-350D0B51-039F-4C56-A52B-35EFF0A089A7Q27011308-74DA3D0C-8C4F-4475-B94B-DFF1CEDC753FQ30357438-79433761-3714-4432-B851-A06DC659FAFBQ30833120-F946BC35-5AA0-4087-AF4D-11DBCDB387EAQ30843648-FE39B50C-60C8-486F-907F-70871CD410ADQ30881753-679748DB-5FF2-49CD-B655-B98854324662Q31117520-3AC0DD54-135B-4C53-816B-3A887BA37F7DQ33739483-B9251B93-FBF1-45DD-AD67-BFF2D32A64FFQ34197452-28BA9461-A945-499D-82F3-E764D8B57E49Q34333651-03C5B79D-2F13-496F-A79C-14D751A004CFQ35028067-81725108-59AC-49AA-B11A-522088A78FB8Q35394095-5276263A-88D8-4844-8C17-43CDA2D3649DQ35413242-E589AB21-9255-429B-98DB-1F886F18CDD9Q35602410-A30CE6D0-9452-4498-9A6E-15678D993D45Q35802992-4A355D5C-68AA-4B25-A3A7-5E6CA78EEBE9Q36204155-F3A4E81E-D360-47D2-B0D8-42C982092DD7Q36260617-236D7F67-FF98-41CB-AF50-95C4A154322EQ36825504-C5814074-8B68-4C10-BDBA-35C11A616CC1Q36856463-1E887ABC-818E-47C3-9B7F-9C663FA64150Q37424582-93EDEE35-0D64-4FEF-A0A2-8EDB6C1E050BQ37443189-0A645322-A137-4999-9929-4465C4BAA6DAQ38157329-ED06CC59-8062-4119-BC3C-B9E65382850DQ38157705-4CE6AAC0-E0B8-4B07-8137-6D4DC3C1DF30Q38612287-AFF067E6-F61F-4392-B010-31C47EFC2817Q38808618-B1BDE66F-7FC2-4296-8B8C-DD1D4299A000Q38917178-C307A465-B442-45F6-BB81-B7509D595F09Q39115205-5D1F32FA-0982-4672-ABD0-584E56BCEEBBQ39340168-A27D564B-973A-43E9-AA00-2A5173B4A64EQ40101878-916A9D5B-DC24-4336-96AA-C695EF5B6941Q40116088-FCAAE6BB-2AFB-45ED-A343-92835A9B6576Q40127918-2642168A-7A9F-4713-A3AC-6CD049219988Q40201595-937509D5-BBCE-4573-8F3D-C3E432D11259Q40253750-EE32FA5E-96E2-4A2E-B7A3-9F6661F525D8Q40336155-B2C9CD5B-B63C-4ECE-A560-0EE8AD6DCD75Q40361969-3F237FE3-83A6-4095-BE40-277ACD1A697AQ40499922-BF5B049B-3596-4055-A778-F2A6E56C6082Q40839225-06D76411-8282-42BE-923A-7426AE16DB7CQ41100504-5D0D61DF-7CCF-4A14-8BA3-61F28A727EC3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helen M. Faddy
@ast
Helen M. Faddy
@en
Helen M. Faddy
@es
Helen M. Faddy
@nl
Helen M. Faddy
@sl
type
label
Helen M. Faddy
@ast
Helen M. Faddy
@en
Helen M. Faddy
@es
Helen M. Faddy
@nl
Helen M. Faddy
@sl
prefLabel
Helen M. Faddy
@ast
Helen M. Faddy
@en
Helen M. Faddy
@es
Helen M. Faddy
@nl
Helen M. Faddy
@sl
P106
P1153
55900666900
P21
P31
P496
0000-0002-3446-8248